India covid-19 reports India

Pfizer expects to produce 80 mn courses of Covid-19 antiviral pill: Report

Reading now: 323

BENGALURU : Pfizer Inc estimates it can manufacture 80 million treatment courses of its experimental COVID-19 antiviral drug, up from a previous forecast of 50 million, a CNBC reporter tweeted on Monday.

Earlier this month, Pfizer said it expects to manufacture 180,000 treatment courses by the end of this year and at least 50 million courses by the end of next year, including 21 million in the first half of 2022.Never miss a story!

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News